VOYA Investment Management
ARIA

VOYA Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

VOYA Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-74,396
Closed -$925K – 2550
2016
Q4 		$925K Hold
74,396
– – ﹤0.01% 1366
2016
Q3 		$1.02K Hold
74,396
– – ﹤0.01% 1306
2016
Q2 		$550K Hold
74,396
– – ﹤0.01% 1645
2016
Q1 		$475K Hold
74,396
– – ﹤0.01% 1719
2015
Q4 		$465K Hold
74,396
– – ﹤0.01% 1768
2015
Q3 		$434K Sell
74,396
-13,033
-15% -$100K ﹤0.01% 1803
2015
Q2 		$723K Sell
87,429
-3,451
-4% -$30.5K ﹤0.01% 1669
2015
Q1 		$749K Hold
90,880
– – ﹤0.01% 1645
2014
Q4 		$624K Hold
90,880
– – ﹤0.01% 1775
2014
Q3 		$491K Hold
90,880
– – ﹤0.01% 1921
2014
Q2 		$579K Sell
90,880
-5,523
-6% -$38K ﹤0.01% 1872
2014
Q1 		$777K Sell
96,403
-627
-0.6% -$4.88K ﹤0.01% 1642
2013
Q4 		$662K Hold
97,030
– – ﹤0.01% 1742
2013
Q3 		$1.78M Sell
97,030
-212
-0.2% -$4.12K ﹤0.01% 1139
2013
Q2 		$1.7M Buy
+97,242
New +$1.72M ﹤0.01% 1134

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

VOYA Investment Management's ARIA Position: Q1 2017 in Review

VOYA Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 74,396 shares — an estimated $925K sold.

VOYA Investment Management first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $1.78M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • VOYA Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • VOYA Investment Management sold 74,396 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $925K.
  • VOYA Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • VOYA Investment Management's Ariad Pharmaceuticals Inc position peaked at $1.78M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on VOYA Investment Management's 13F filing for Q1 2017, filed 15 May 2017.